Pharmacokinetic comparability of Prolastin(®)-C to Prolastin(® )in alpha(1)-antitrypsin deficiency: a randomized study

BACKGROUND: Alpha(1)-antitrypsin (AAT) deficiency is characterized by low blood levels of alpha(1)-proteinase inhibitor (alpha(1)-PI) and may lead to emphysema. Alpha(1)-PI protects pulmonary tissue from damage caused by the action of proteolytic enzymes. Augmentation therapy with Prolastin(® )(Alph...

Descripción completa

Detalles Bibliográficos
Autores principales: Stocks, James M, Brantly, Mark L, Wang-Smith, Laurene, Campos, Michael A, Chapman, Kenneth R, Kueppers, Friedrich, Sandhaus, Robert A, Strange, Charlie, Turino, Gerard
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958874/
https://www.ncbi.nlm.nih.gov/pubmed/20920295
http://dx.doi.org/10.1186/1472-6904-10-13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958874/
https://www.ncbi.nlm.nih.gov/pubmed/20920295
http://dx.doi.org/10.1186/1472-6904-10-13

Ejemplares similares